These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 37192820)
1. Novel Tracers for the Imaging of Cardiac Amyloidosis. Shetty M; Malhotra S J Nucl Med Technol; 2023 Jun; 51(2):120-124. PubMed ID: 37192820 [TBL] [Abstract][Full Text] [Related]
3. Molecular imaging of amyloidosis: will the heart be the next target after the brain? Chen W; Dilsizian V Curr Cardiol Rep; 2012 Apr; 14(2):226-33. PubMed ID: 22193845 [TBL] [Abstract][Full Text] [Related]
4. Clinical Phenotyping of Transthyretin Cardiac Amyloidosis with Bone-Seeking Radiotracers in Heart Failure with Preserved Ejection Fraction. Chen W; Ton VK; Dilsizian V Curr Cardiol Rep; 2018 Mar; 20(4):23. PubMed ID: 29520480 [TBL] [Abstract][Full Text] [Related]
5. Advances in PET-Based Cardiac Amyloid Radiotracers. Gallegos C; Miller EJ Curr Cardiol Rep; 2020 May; 22(6):40. PubMed ID: 32430600 [TBL] [Abstract][Full Text] [Related]
6. Radionuclide Imaging of Cardiac Amyloidosis and Sarcoidosis: Roles and Characteristics of Various Tracers. Hotta M; Minamimoto R; Awaya T; Hiroe M; Okazaki O; Hiroi Y Radiographics; 2020; 40(7):2029-2041. PubMed ID: 32976061 [TBL] [Abstract][Full Text] [Related]
7. Cardiac Scintigraphy With Technetium-99m-Labeled Bone-Seeking Tracers for Suspected Amyloidosis: JACC Review Topic of the Week. Hanna M; Ruberg FL; Maurer MS; Dispenzieri A; Dorbala S; Falk RH; Hoffman J; Jaber W; Soman P; Witteles RM; Grogan M J Am Coll Cardiol; 2020 Jun; 75(22):2851-2862. PubMed ID: 32498813 [TBL] [Abstract][Full Text] [Related]
8. A challenging road to diagnosing transthyretin cardiac amyloidosis and using technetium-99m pyrophosphate bone scintigraphy in nuclear cardiology - A case report. Kavita A; Abdul Onny MA; Suppiah S; Abdul Aziz AF; Hashim H; Raja Shariff RE; Ng CS Med J Malaysia; 2021 Sep; 76(5):762-767. PubMed ID: 34508392 [TBL] [Abstract][Full Text] [Related]
9. Non-invasive detection and differentiation of cardiac amyloidosis using Takasone K; Katoh N; Takahashi Y; Abe R; Ezawa N; Yoshinaga T; Yanagisawa S; Yazaki M; Oguchi K; Koyama J; Sekijima Y Amyloid; 2020 Dec; 27(4):266-274. PubMed ID: 32722948 [TBL] [Abstract][Full Text] [Related]
10. Temporal Trends in Diagnostic Testing Patterns for Wild-Type Transthyretin Amyloid Cardiomyopathy in the Medicare Fee-for-Service Population. Bourque JM; Schepart A; Bhambri R; Castaño A; O'Brien A; Chen Y; Prasad S; Roy A; Grodin JL Am J Cardiol; 2022 Mar; 167():98-103. PubMed ID: 35022130 [TBL] [Abstract][Full Text] [Related]
11. Validation of the Kumamoto criteria for prediction of Ochi Y; Kubo T; Baba Y; Ueda M; Miyagawa K; Noguchi T; Hirota T; Yamasaki N; Kitaoka H J Cardiol; 2021 Feb; 77(2):124-130. PubMed ID: 33132078 [TBL] [Abstract][Full Text] [Related]
12. Radiolabeled Thioflavin-T Derivative PET Imaging for the Assessment of Cardiac Amyloidosis. Boczar KE; Small G; Tavoosi A; Ruddy TD Curr Cardiol Rep; 2022 Dec; 24(12):1883-1891. PubMed ID: 36378483 [TBL] [Abstract][Full Text] [Related]
13. Diagnosing Transthyretin Cardiac Amyloidosis by Technetium Tc 99m Pyrophosphate: A Test in Evolution. Poterucha TJ; Elias P; Bokhari S; Einstein AJ; DeLuca A; Kinkhabwala M; Johnson LL; Flaherty KR; Saith SE; Griffin JM; Perotte A; Maurer MS JACC Cardiovasc Imaging; 2021 Jun; 14(6):1221-1231. PubMed ID: 33221204 [TBL] [Abstract][Full Text] [Related]
14. The Role of Molecular Imaging in the Assessment of Cardiac Amyloidosis: State-of-the-Art. Popescu C; Burger IA Curr Radiopharm; 2021; 14(3):228-241. PubMed ID: 32525789 [TBL] [Abstract][Full Text] [Related]
15. Usefulness of (99m)Tc-HMDP scintigraphy for the etiologic diagnosis and prognosis of cardiac amyloidosis. Galat A; Rosso J; Guellich A; Van Der Gucht A; Rappeneau S; Bodez D; Guendouz S; Tissot CM; Hittinger L; Dubois-Randé JL; Plante-Bordeneuve V; Itti E; Meignan M; Damy T Amyloid; 2015; 22(4):210-20. PubMed ID: 26465835 [TBL] [Abstract][Full Text] [Related]
16. [Bone seeking tracers' scintigraphy for the diagnosis of transthyretin cardiac amyloidosis]. Daquarti GJ; Meretta A; Corneli M; Costabel JP; Diez M; Masoli OH Medicina (B Aires); 2018; 78(6):395-398. PubMed ID: 30504105 [TBL] [Abstract][Full Text] [Related]
17. [Cardiac scintigraphy-centered diagnostic process in transthyretin cardiac amyloidosis]. Ak Sivrikoz I; Çavuşoğlu Y Turk Kardiyol Dern Ars; 2020 Jul; 48(5):514-521. PubMed ID: 32633270 [TBL] [Abstract][Full Text] [Related]